Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices
BACKGROUNDThe aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for...
Gespeichert in:
Veröffentlicht in: | Dermatologic surgery 2016-05, Vol.42 (5), p.586-597 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 597 |
---|---|
container_issue | 5 |
container_start_page | 586 |
container_title | Dermatologic surgery |
container_volume | 42 |
creator | Carruthers, Jean Burgess, Cheryl Day, Doris Fabi, Sabrina G Goldie, Kate Kerscher, Martina Nikolis, Andreas Pavicic, Tatjana Rho, Nark-Kyoung Rzany, Berthold Sattler, Gerhard Sattler, Sonja Seo, Kyle Werschler, William Philip Carruthers, Alastair |
description | BACKGROUNDThe aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for a pan-facial approach using multiple interventions have been published to date.
OBJECTIVETo develop consensus recommendations for the optimal combination and ideal sequence of botulinum toxin (BoNT), hyaluronic acid, calcium hydroxylapatite, and microfocused ultrasound with visualization (MFU-V) in persons of all Fitzpatrick skin types.
METHODS AND MATERIALSFifteen specialists convened under the guidance of a certified moderator. Consensus was defined as approval from 75% to 94% of all participants, whereas agreement of ≥95% denoted a strong consensus.
RESULTSOptimal aesthetic treatment of the face begins with a thorough patient assessment and an individualized treatment plan. Spacing consecutive treatments 1 to 2 weeks apart allows for resolution of side effects and/or to assess results. For same-day treatments, BoNT and fillers may be performed together in either sequence, whereas MFU-V is recommended before injectable agents.
CONCLUSIONExpert consensus supports a combination approach using multiple modalities in specific sequence for the safe and effective treatment of the aging face. |
doi_str_mv | 10.1097/DSS.0000000000000754 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785741393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1785741393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3564-da0bd2523edf81981cd9ff3757fddbe2272fd957423fc239c774fa7de5a50be63</originalsourceid><addsrcrecordid>eNp9kM1OGzEUhS3UqqG0b4AqL1kw4J9xnFlCQkokpEqFrEce-zpx67GpPcPPui9eowBCLOqNravvnCt_CB1SckJJI08X19cn5O2Rot5D-1SwuqolEx_Km8hpRQRlE_Q551-EUNZw8glNmKSENFO2j_7OY8gQ8pjxT9Cx7yEYNbgyxDYmPI995wIYfAZ52MLgNF6FAdIdhB3kAi5zvFQa8Dq7sMHncRi9C2OPb-KDC8d46byHlI-xCgZfBEibx-pc5VK6gDunIX9BH63yGb4-3wdovby4mV9WVz--r-ZnV5XmYlpXRpHOMME4GDujzYxq01jLpZDWmA4Yk8yaRsiacasZb7SUtVXSgFCCdDDlB-ho13ub4p-xfKjtXdbgvQoQx9xSOStpyhte0HqH6hRzTmDb2-R6lR5bSton_W3R377XX2LfnjeMXQ_mNfTiuwCzHXAffdGYf_vxHlK7BeWH7f-7_wGKzJMq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1785741393</pqid></control><display><type>article</type><title>Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Carruthers, Jean ; Burgess, Cheryl ; Day, Doris ; Fabi, Sabrina G ; Goldie, Kate ; Kerscher, Martina ; Nikolis, Andreas ; Pavicic, Tatjana ; Rho, Nark-Kyoung ; Rzany, Berthold ; Sattler, Gerhard ; Sattler, Sonja ; Seo, Kyle ; Werschler, William Philip ; Carruthers, Alastair</creator><creatorcontrib>Carruthers, Jean ; Burgess, Cheryl ; Day, Doris ; Fabi, Sabrina G ; Goldie, Kate ; Kerscher, Martina ; Nikolis, Andreas ; Pavicic, Tatjana ; Rho, Nark-Kyoung ; Rzany, Berthold ; Sattler, Gerhard ; Sattler, Sonja ; Seo, Kyle ; Werschler, William Philip ; Carruthers, Alastair</creatorcontrib><description>BACKGROUNDThe aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for a pan-facial approach using multiple interventions have been published to date.
OBJECTIVETo develop consensus recommendations for the optimal combination and ideal sequence of botulinum toxin (BoNT), hyaluronic acid, calcium hydroxylapatite, and microfocused ultrasound with visualization (MFU-V) in persons of all Fitzpatrick skin types.
METHODS AND MATERIALSFifteen specialists convened under the guidance of a certified moderator. Consensus was defined as approval from 75% to 94% of all participants, whereas agreement of ≥95% denoted a strong consensus.
RESULTSOptimal aesthetic treatment of the face begins with a thorough patient assessment and an individualized treatment plan. Spacing consecutive treatments 1 to 2 weeks apart allows for resolution of side effects and/or to assess results. For same-day treatments, BoNT and fillers may be performed together in either sequence, whereas MFU-V is recommended before injectable agents.
CONCLUSIONExpert consensus supports a combination approach using multiple modalities in specific sequence for the safe and effective treatment of the aging face.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1097/DSS.0000000000000754</identifier><identifier>PMID: 27100962</identifier><language>eng</language><publisher>United States: by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Biocompatible Materials - therapeutic use ; Botulinum Toxins, Type A - therapeutic use ; Combined Modality Therapy ; Cosmetic Techniques ; Dermal Fillers - therapeutic use ; Durapatite - therapeutic use ; Esthetics ; Face ; Humans ; Hyaluronic Acid - therapeutic use ; Rejuvenation ; Skin Aging ; Ultrasonic Therapy - methods ; Viscosupplements - therapeutic use</subject><ispartof>Dermatologic surgery, 2016-05, Vol.42 (5), p.586-597</ispartof><rights>2016 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3564-da0bd2523edf81981cd9ff3757fddbe2272fd957423fc239c774fa7de5a50be63</citedby><cites>FETCH-LOGICAL-c3564-da0bd2523edf81981cd9ff3757fddbe2272fd957423fc239c774fa7de5a50be63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23929,23930,25139,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27100962$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carruthers, Jean</creatorcontrib><creatorcontrib>Burgess, Cheryl</creatorcontrib><creatorcontrib>Day, Doris</creatorcontrib><creatorcontrib>Fabi, Sabrina G</creatorcontrib><creatorcontrib>Goldie, Kate</creatorcontrib><creatorcontrib>Kerscher, Martina</creatorcontrib><creatorcontrib>Nikolis, Andreas</creatorcontrib><creatorcontrib>Pavicic, Tatjana</creatorcontrib><creatorcontrib>Rho, Nark-Kyoung</creatorcontrib><creatorcontrib>Rzany, Berthold</creatorcontrib><creatorcontrib>Sattler, Gerhard</creatorcontrib><creatorcontrib>Sattler, Sonja</creatorcontrib><creatorcontrib>Seo, Kyle</creatorcontrib><creatorcontrib>Werschler, William Philip</creatorcontrib><creatorcontrib>Carruthers, Alastair</creatorcontrib><title>Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUNDThe aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for a pan-facial approach using multiple interventions have been published to date.
OBJECTIVETo develop consensus recommendations for the optimal combination and ideal sequence of botulinum toxin (BoNT), hyaluronic acid, calcium hydroxylapatite, and microfocused ultrasound with visualization (MFU-V) in persons of all Fitzpatrick skin types.
METHODS AND MATERIALSFifteen specialists convened under the guidance of a certified moderator. Consensus was defined as approval from 75% to 94% of all participants, whereas agreement of ≥95% denoted a strong consensus.
RESULTSOptimal aesthetic treatment of the face begins with a thorough patient assessment and an individualized treatment plan. Spacing consecutive treatments 1 to 2 weeks apart allows for resolution of side effects and/or to assess results. For same-day treatments, BoNT and fillers may be performed together in either sequence, whereas MFU-V is recommended before injectable agents.
CONCLUSIONExpert consensus supports a combination approach using multiple modalities in specific sequence for the safe and effective treatment of the aging face.</description><subject>Biocompatible Materials - therapeutic use</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Cosmetic Techniques</subject><subject>Dermal Fillers - therapeutic use</subject><subject>Durapatite - therapeutic use</subject><subject>Esthetics</subject><subject>Face</subject><subject>Humans</subject><subject>Hyaluronic Acid - therapeutic use</subject><subject>Rejuvenation</subject><subject>Skin Aging</subject><subject>Ultrasonic Therapy - methods</subject><subject>Viscosupplements - therapeutic use</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1OGzEUhS3UqqG0b4AqL1kw4J9xnFlCQkokpEqFrEce-zpx67GpPcPPui9eowBCLOqNravvnCt_CB1SckJJI08X19cn5O2Rot5D-1SwuqolEx_Km8hpRQRlE_Q551-EUNZw8glNmKSENFO2j_7OY8gQ8pjxT9Cx7yEYNbgyxDYmPI995wIYfAZ52MLgNF6FAdIdhB3kAi5zvFQa8Dq7sMHncRi9C2OPb-KDC8d46byHlI-xCgZfBEibx-pc5VK6gDunIX9BH63yGb4-3wdovby4mV9WVz--r-ZnV5XmYlpXRpHOMME4GDujzYxq01jLpZDWmA4Yk8yaRsiacasZb7SUtVXSgFCCdDDlB-ho13ub4p-xfKjtXdbgvQoQx9xSOStpyhte0HqH6hRzTmDb2-R6lR5bSton_W3R377XX2LfnjeMXQ_mNfTiuwCzHXAffdGYf_vxHlK7BeWH7f-7_wGKzJMq</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Carruthers, Jean</creator><creator>Burgess, Cheryl</creator><creator>Day, Doris</creator><creator>Fabi, Sabrina G</creator><creator>Goldie, Kate</creator><creator>Kerscher, Martina</creator><creator>Nikolis, Andreas</creator><creator>Pavicic, Tatjana</creator><creator>Rho, Nark-Kyoung</creator><creator>Rzany, Berthold</creator><creator>Sattler, Gerhard</creator><creator>Sattler, Sonja</creator><creator>Seo, Kyle</creator><creator>Werschler, William Philip</creator><creator>Carruthers, Alastair</creator><general>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201605</creationdate><title>Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices</title><author>Carruthers, Jean ; Burgess, Cheryl ; Day, Doris ; Fabi, Sabrina G ; Goldie, Kate ; Kerscher, Martina ; Nikolis, Andreas ; Pavicic, Tatjana ; Rho, Nark-Kyoung ; Rzany, Berthold ; Sattler, Gerhard ; Sattler, Sonja ; Seo, Kyle ; Werschler, William Philip ; Carruthers, Alastair</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3564-da0bd2523edf81981cd9ff3757fddbe2272fd957423fc239c774fa7de5a50be63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biocompatible Materials - therapeutic use</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Cosmetic Techniques</topic><topic>Dermal Fillers - therapeutic use</topic><topic>Durapatite - therapeutic use</topic><topic>Esthetics</topic><topic>Face</topic><topic>Humans</topic><topic>Hyaluronic Acid - therapeutic use</topic><topic>Rejuvenation</topic><topic>Skin Aging</topic><topic>Ultrasonic Therapy - methods</topic><topic>Viscosupplements - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carruthers, Jean</creatorcontrib><creatorcontrib>Burgess, Cheryl</creatorcontrib><creatorcontrib>Day, Doris</creatorcontrib><creatorcontrib>Fabi, Sabrina G</creatorcontrib><creatorcontrib>Goldie, Kate</creatorcontrib><creatorcontrib>Kerscher, Martina</creatorcontrib><creatorcontrib>Nikolis, Andreas</creatorcontrib><creatorcontrib>Pavicic, Tatjana</creatorcontrib><creatorcontrib>Rho, Nark-Kyoung</creatorcontrib><creatorcontrib>Rzany, Berthold</creatorcontrib><creatorcontrib>Sattler, Gerhard</creatorcontrib><creatorcontrib>Sattler, Sonja</creatorcontrib><creatorcontrib>Seo, Kyle</creatorcontrib><creatorcontrib>Werschler, William Philip</creatorcontrib><creatorcontrib>Carruthers, Alastair</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carruthers, Jean</au><au>Burgess, Cheryl</au><au>Day, Doris</au><au>Fabi, Sabrina G</au><au>Goldie, Kate</au><au>Kerscher, Martina</au><au>Nikolis, Andreas</au><au>Pavicic, Tatjana</au><au>Rho, Nark-Kyoung</au><au>Rzany, Berthold</au><au>Sattler, Gerhard</au><au>Sattler, Sonja</au><au>Seo, Kyle</au><au>Werschler, William Philip</au><au>Carruthers, Alastair</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2016-05</date><risdate>2016</risdate><volume>42</volume><issue>5</issue><spage>586</spage><epage>597</epage><pages>586-597</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUNDThe aging process is a complex interplay of intrinsic and extrinsic factors across multiple layers of the face. Accordingly, combining aesthetic interventions targeting different manifestations of aging often leads to better results than single modalities alone. However, no guidelines for a pan-facial approach using multiple interventions have been published to date.
OBJECTIVETo develop consensus recommendations for the optimal combination and ideal sequence of botulinum toxin (BoNT), hyaluronic acid, calcium hydroxylapatite, and microfocused ultrasound with visualization (MFU-V) in persons of all Fitzpatrick skin types.
METHODS AND MATERIALSFifteen specialists convened under the guidance of a certified moderator. Consensus was defined as approval from 75% to 94% of all participants, whereas agreement of ≥95% denoted a strong consensus.
RESULTSOptimal aesthetic treatment of the face begins with a thorough patient assessment and an individualized treatment plan. Spacing consecutive treatments 1 to 2 weeks apart allows for resolution of side effects and/or to assess results. For same-day treatments, BoNT and fillers may be performed together in either sequence, whereas MFU-V is recommended before injectable agents.
CONCLUSIONExpert consensus supports a combination approach using multiple modalities in specific sequence for the safe and effective treatment of the aging face.</abstract><cop>United States</cop><pub>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>27100962</pmid><doi>10.1097/DSS.0000000000000754</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1076-0512 |
ispartof | Dermatologic surgery, 2016-05, Vol.42 (5), p.586-597 |
issn | 1076-0512 1524-4725 |
language | eng |
recordid | cdi_proquest_miscellaneous_1785741393 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Biocompatible Materials - therapeutic use Botulinum Toxins, Type A - therapeutic use Combined Modality Therapy Cosmetic Techniques Dermal Fillers - therapeutic use Durapatite - therapeutic use Esthetics Face Humans Hyaluronic Acid - therapeutic use Rejuvenation Skin Aging Ultrasonic Therapy - methods Viscosupplements - therapeutic use |
title | Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A00%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consensus%20Recommendations%20for%20Combined%20Aesthetic%20Interventions%20in%20the%20Face%20Using%20Botulinum%20Toxin,%20Fillers,%20and%20Energy-Based%20Devices&rft.jtitle=Dermatologic%20surgery&rft.au=Carruthers,%20Jean&rft.date=2016-05&rft.volume=42&rft.issue=5&rft.spage=586&rft.epage=597&rft.pages=586-597&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1097/DSS.0000000000000754&rft_dat=%3Cproquest_cross%3E1785741393%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1785741393&rft_id=info:pmid/27100962&rfr_iscdi=true |